Page last updated: 2024-10-16

carnitine and Gigantism

carnitine has been researched along with Gigantism in 2 studies

Gigantism: The condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.

Research Excerpts

ExcerptRelevanceReference
"L-Carnitine treatment led to gradual improvement in exercise tolerance and cognitive performance; plasma and tissue carnitine levels returned to normal, and echocardiographic evidence of left ventricular hypertrophy disappeared."1.30Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome. ( Bittner, RE; Gross, M; Marx, M; Skyllouriotis, ML; Skyllouriotis, P; Wimmer, M, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Powell, BR1
Budden, SS1
Buist, NR1
Skyllouriotis, ML1
Marx, M1
Bittner, RE1
Skyllouriotis, P1
Gross, M1
Wimmer, M1

Other Studies

2 other studies available for carnitine and Gigantism

ArticleYear
Dominantly inherited megalencephaly, muscle weakness, and myoliposis: a carnitine-deficient myopathy within the spectrum of the Ruvalcaba-Myhre-Smith syndrome.
    The Journal of pediatrics, 1993, Volume: 123, Issue:1

    Topics: Abnormalities, Multiple; Administration, Oral; Biopsy, Needle; Brain; Carnitine; Child; Child, Presc

1993
Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
    Pediatric neurology, 1997, Volume: 17, Issue:1

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; AMP Deaminase; Biopsy; Cardiomyopathy, Hypertr

1997